Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer
- Registration Number
- NCT01190657
- Lead Sponsor
- Eisai Co., Ltd.
- Brief Summary
This is a self-controlled, open, multiple-center clinical trial.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1184
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Selbex 50mg (14 days) Selbex - Selbex 50mg (56 days) Selbex -
- Primary Outcome Measures
Name Time Method Endoscopic results of ulcer lesion 56 days Heal rate = (healed cases + significant improved cases)/total cases administered ×100 %
Total effective rate 56 days. Total effective rate = (healed cases + significant improved cases + effective cases)/total cases administered ×100 %.
- Secondary Outcome Measures
Name Time Method Symptoms improved level 56 days
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (26)
Chinese People's Liberation Army General Hospital of Beijing Military
🇨🇳Beijing, China
Chongqing First People's Hospital
🇨🇳Chongqing, China
The Second Affiliated Hospital of Chongqing Medical University
🇨🇳Chongqing, China
Wuhan Union Hospital
🇨🇳Hubei, China
Changsha Central Hospital
🇨🇳Hunan, China
Hunan Provincial People's Hospital
🇨🇳Hunan, China
Nanjing First Hospital
🇨🇳Jiangsu, China
Nanjing General Hospital of Nanjing Military Command
🇨🇳Jiangsu, China
The Second Affiliated Hospital of Nanjing Medical University
🇨🇳Jiangsu, China
The Second Affiliated Hospital of Suzhou University
🇨🇳Jiangsu, China
Scroll for more (16 remaining)Chinese People's Liberation Army General Hospital of Beijing Military🇨🇳Beijing, China